Progyny, Inc.

Nasdaq:PGNY

Services-Misc Health & Allied Services, NEC·NEW YORK, NY

CEO

Anevski Peter

CFO

Livingston Mark S.

Summary Financials

Revenue

$1.1B

+38.3% YoY

FY 2025

Adj. EBITDA

$64.5M

5.9% margin

FY 2025

Net Income

$62.0M

5.7% margin

FY 2025

EPS (Diluted)

$0.62

FY 2025

Stock Price

$18.25

-0.3%

2026-03-09

52W Range

$16.75 – $28.75

P/E Ratio

29.4x

Market Cap

$1.5B

Cash

$97.3M

FY 2025

Total Debt

$253,000

FY 2019

Net Cash

$97.0M

FY 2019

Enterprise Value

$1.4B

Debt / EBITDA

-1.5x

FY 2025

EV / EBITDA

21.7x

Employees

—

Revenue

$1.1B

+38.3% YoY

FY 2025

Adj. EBITDA

$64.5M

5.9% margin

FY 2025

Net Income

$62.0M

5.7% margin

FY 2025

EPS (Diluted)

$0.62

FY 2025

Stock Price

$18.25

-0.3%

2026-03-09

52W Range

$16.75 – $28.75

P/E Ratio

29.4x

Market Cap

$1.5B

Cash

$97.3M

FY 2025

Total Debt

$253,000

FY 2019

Net Cash

$97.0M

FY 2019

Enterprise Value

$1.4B

Debt / EBITDA

-1.5x

FY 2025

EV / EBITDA

21.7x

Employees

—